相关实验视频

Updated: Mar 11, 2026

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

日本CAR-T电池产品的现状和问题:监管视角

Miki Nakamura¹, Shinich Noda², Atsushi Nishikawa²

¹Pharmaceuticals and Medical Devices Agency, 3-3-2 Kasumigaseki, Tokyo, Chiyoda-Ku, 100-0013, Japan. nakamura-miki@pmda.go.jp.

International journal of hematology

|March 9, 2026

概括

化学抗原受体 (CAR) -T细胞疗法对血液恶性瘤有显著的前景,但面临着挑战. 本综述详细介绍了日本CAR-T产品的监管考虑和制造问题.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
细胞疗法细胞疗法

背景情况:

化学抗原受体 (CAR) -T细胞疗法是一个快速发展的领域,具有显著的临床影响.
已批准的CAR-T产品针对复发性/耐药性血液恶性瘤的CD19或B细胞成熟抗原 (BCMA).
尽管有效,但CAR-T疗法面临诸多挑战,包括高成本和未解决的问题.

研究的目的:

概述日本制药和医疗器械局 (PMDA) 审查的CAR-T细胞产品的问题和考虑因素.
描述监管批准过程,说明和CAR-T细胞的制造.
突出监管审查的关键方面,重点关注临床评估.

主要方法:

审查与日本CAR-T细胞产品有关的监管文件和指南.
对CAR-T电池产品的批准过程和制造考虑的分析.
对CAR-T细胞治疗的临床评估策略的检查.

主要成果:

日本的CAR-T细胞产品已被批准用于特定的复发性或耐药性血液癌症.
该审查涵盖批准途径,最佳临床使用和制造,包括超标产品.
关键的监管考虑侧重于临床试验设计和CAR-T产品的评估.

结论:

卡特-T细胞疗法提供了持久的反应,但需要仔细监管监督.
解决制造挑战和定义最佳临床用途对于更广泛的采用至关重要.
像PMDA这样的机构的监管审查对于确保新型CAR-T细胞疗法的安全性和有效性至关重要.

关键词:

在CAR-T细胞疗法中.血液性恶性瘤血液性恶性瘤在规范之外的规格.制药和医疗器械机构药品和医疗器械机构

更多相关视频

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

相关概念视频

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.